Ticker Details
Aquestive Therapeutics, Inc.
IPO Date:	July 23, 2018
Sector:	Healthcare
Industry:	Drug Manufacturers - Specialty and Generic
Market Cap:	$481.91M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.16 | 3.69%
Avg Daily Range (30 D):	$0.12 | 3.27%
Avg Daily Range (90 D):	$0.17 | 3.12%

Institutional Daily Volume
Avg Daily Volume:	.94M
Avg Daily Volume (30 D):	6.78M
Avg Daily Volume (90 D):	3.87M

Trade Size
Avg Trade Size (Sh.):	181
Avg Trade Size (Sh.) (30 D):	217
Avg Trade Size (Sh.) (90 D):	169

Institutional Trades
Total Institutional Trades:	276
Avg Institutional Trade:	$1.57M
Avg Institutional Trade (30 D):	$.91M
Avg Institutional Trade (90 D):	$1.3M
Avg Institutional Trade Volume:	.36M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.6M
Avg Closing Trade (30 D):	$.9M
Avg Closing Trade (90 D):	$1.28M
Avg Closing Volume:	338.82K

News

Feb 24, 2026 @ 12:00 PM Aquestive Therapeutics to Report Fourth Quarter 20... Source: Na

Feb 20, 2026 @ 12:00 PM Aquestive Therapeutics to Present New Clinical Dat... Source: Na

Feb 15, 2026 @ 1:12 PM AQST SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, L... Source: Faruqi & Faruqi, Llp

Feb 4, 2026 @ 1:13 AM INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates ... Source: Faruqi & Faruqi, Llp

Feb 2, 2026 @ 6:24 PM AQST Investors Have Opportunity to Join Aquestive ... Source: Business Wire

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-.7	$-.14	$-.14
Diluted EPS	$-.7	$-.14	$-.14
Revenue	$43.4M	$12.81M	$10M
Gross Profit	$26.16M	$8.3M	$5.44M
Net Income / Loss	$-68.98M	$-15.45M	$-13.55M
Operating Income / Loss	$-55.79M	$-11.48M	$-11.37M
Cost of Revenue	$17.24M	$4.51M	$4.56M
Net Cash Flow	$51.17M	$68.53M	$-8.12M
PE Ratio